Today's Rundown Featured Story | | | Monday, July 2, 2018 MiMedx’s board of directors has decided to replace its president and its CEO as a result of an ongoing internal investigation and federal probes into its accounting and sales compliance practices, less than a month after the company said it would need to restate five years’ worth of financial disclosures. |
|
|
Top Stories Monday, July 2, 2018 China’s I-Mab Biopharma just raised a massive $220 million in a third-round fundraising that once again reveals the growing strength of the country’s emerging biotech sector. Monday, July 2, 2018 Liquidia Technologies has filed for a $57.5 million IPO to take its twist on United Therapeutics’ Tyvaso through phase 3. The experimental pulmonary arterial hypertension (PAH) candidate is a dry powder formulation of the active ingredient in Tyvaso. Monday, July 2, 2018 Athenex is picking up a $100 million investment from Perceptive Advisors, licensing a modified cancer-fighting enzyme and launching a new Chinese joint venture built around T-cell receptor (TCR) technology. Monday, July 2, 2018 PredictImmune has named Paul Kinnon as its CEO. Kinnon, a former Life Technologies VP, has spent most of the past decade running diagnostic businesses Transgenomic and ZyGEM. Monday, July 2, 2018 NHS Digital, which provides information, data and IT services for the U.K.’s National Health Service, inked a deal with privacy engineering software provider Privitar to up its game in protecting patient information. Monday, July 2, 2018 Pharma's promo enforcers at the FDA slapped Pfizer with an untitled letter—only their second this year—for skipping risk information in a video for its postmenopausal hormonal drug Estring. Enrollment Showcase | | | Sponsored by: Bioinformatics at UTHealth SBMI UTHealth SBMI now offers a M.S. track in clinical and translational bioinformatics. |
|
|
Resources Life Science Strategy Group Take this anonymous 10-minute survey to share your thoughts on leading eClinical technology solutions and earn up to $55 honoraria. Take the survey now! Sponsored by: Blue Latitude Health Blue Latitude Health explores the commercial barriers and new stakeholder connections for pharma companies developing precision medicines, and reveals how to grasp novel opportunities in the new era of healthcare. Presented by: Patheon, part of Thermo Fisher Scientific “Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. | 
